Current management strategy of hepatocellular carcinoma

被引:111
作者
Rampone, Bernardino [1 ]
Schiavone, Beniamino [1 ]
Martino, Antonio [1 ]
Viviano, Carmine [1 ]
Confuorto, Giuseppe [1 ]
机构
[1] Pineta Grande Hosp, Dept Surg, I-81100 Castel Volturno, Caserta, Italy
关键词
Hepatocellular carcinoma; Locoregional procedures; Liver transplantation; Surgical resection; Systemic treatment; ORTHOTOPIC LIVER-TRANSPLANTATION; LONG-TERM PROGNOSIS; HEPATITIS-C-VIRUS; RADIOFREQUENCY ABLATION; SURGICAL-TREATMENT; UNITED-STATES; ARTERIAL EMBOLIZATION; VASCULAR INVASION; ETHANOL INJECTION; RESECTION;
D O I
10.3748/wjg.15.3210
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocellular carcinoma (HCC) still remains a considerable challenge for surgeons. Surgery, including liver transplantation, is the most important therapeutic approach for patients with this disease. HCC is frequently diagnosed at advanced stages and has a poor prognosis with a high mortality rate even when surgical resection has been considered potentially curative. This brief report summarizes the current status of the management of this malignancy and includes a short description of new pharmacological approaches in HCC treatment. (C) 2009 The WJG Press and Baishideng. All rights reserved.
引用
收藏
页码:3210 / 3216
页数:7
相关论文
共 85 条
[61]   Early and late complications in the right-lobe adult living donor [J].
Pomfret, EA .
LIVER TRANSPLANTATION, 2003, 9 (10) :S45-S49
[62]   Locoregional therapies for hepatocellular carcinoma: A critical review from the surgeon's perspective [J].
Poon, RTP ;
Fan, ST ;
Tsang, FHF ;
Wong, J .
ANNALS OF SURGERY, 2002, 235 (04) :466-486
[63]  
Ringe Burckhardt, 1997, P513
[64]   Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: A western experience [J].
Roayaie, S ;
Ben Haim, M ;
Emre, S ;
Fishbein, TM ;
Sheiner, PA ;
Miller, CM ;
Schwartz, ME .
ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (10) :764-770
[65]   Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: A retrospective multicenter study [J].
Ryu, M ;
Shimamura, Y ;
Kinoshita, T ;
Konishi, M ;
Kawano, N ;
Iwasaki, M ;
Furuse, J ;
Yoshino, M ;
Moriyama, N ;
Sugita, M .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1997, 27 (04) :251-257
[66]   MELD score predicts 1-year patient survival post-orthotopic liver transplantation [J].
Saab, S ;
Wang, V ;
Ibrahim, AB ;
Durazo, F ;
Han, S ;
Farmer, DG ;
Yersiz, H ;
Morrisey, M ;
Goldstein, LI ;
Ghobrial, RM ;
Busuttil, RW .
LIVER TRANSPLANTATION, 2003, 9 (05) :473-476
[67]   Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective [J].
Sarasin, FP ;
Giostra, E ;
Mentha, G ;
Hadengue, A .
HEPATOLOGY, 1998, 28 (02) :436-442
[68]   Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials [J].
Schwartz, JD ;
Schwartz, M ;
Mandeli, J ;
Sung, M .
LANCET ONCOLOGY, 2002, 3 (10) :593-603
[69]   Longterm prognosis after hepatic resection for small hepatocellular carcinoma [J].
Shimozawa, N ;
Hanazaki, K .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2004, 198 (03) :356-365
[70]   A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades [J].
Tanaka, Y ;
Hanada, K ;
Mizokami, M ;
Yeo, AET ;
Shih, JWK ;
Gojobori, T ;
Alter, HJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) :15584-15589